Skip to product information
1 of 1

SOLAL

Homocysteine Lowering Formula

Homocysteine Lowering Formula

Regular price R 200
Regular price Sale price R 200
Sale Sold out
Tax included.

Nappi code: 704934-001

Size

Out of stock

  • Secure payment via PayFast, Zapper, Mobicred, Peach Payments or Ozow
  • Professional grade products recommended by healthcare practitioners, delivered directly to your door.
Thanks for signing up for restock notifications!
There was an error signing up for restock notifications. Please try again.

Sign up for restock notifications

Notify Me
View full details

PRODUCT DESCRIPTION

Homocysteine Lowering Formula by SOLAL® contains a combination of vitamins, folate, inositol and zinc important in the methylation cycle. The methylation cycle in cells is responsible for converting homocysteine to methionine. High levels of homocysteine is associated with increased risk of neurological and heart disease.

RECOMMENDED USAGE

Adults: Take one capsule daily with food.

COMPOSITION

Serving size : 1 capsule Amount per serving
Inositol 242,5 mg
Zinc amino acid chelate 100,0 mg
     providing zinc 20,0 mg
Pyridoxal-5-phosphate (vitamin B6) 68,5 mg
Riboflavin-5-phosphate (vitamin B2) 13,3 mg
L-5-methyltetrahydrofolate calcium 543,0 mcg
     providing folate 500,0 mcg
Methylcobalamin (vitamin B12) 98,5 mcg


OTHER INGREDIENTS

Magnesium stearate, microcrystalline cellulose and talc

Contains sugar: Inositol 0,25 g/tablet

DOES NOT CONTAIN

Suitable for vegans and vegetarians

STORAGE

Store in a cool dry place (<25°C), away from sunlight. Keep out of reach of children. 

PRODUCT FORM

Capsule

WARNINGS/CONTRAINDICATION

If pregnant, nursing or taking medication, consult your healthcare practitioner before use. 

Do not use this product if you have an allergy or sensitivity to any of the ingredients.

If you are on any medication or suffering from any medical condition, it is advisable to seek medical advice before starting any new medicine, supplement or remedy.

Do not exceed recommended dosage(s) unless on the advice of a healthcare practitioner. 

Carbamazepine, lithium and valproic acid reduce the level of inositol in the brain by inhibiting enzymes responsible for inositol production in the brain.

The effect on brain inositol levels may contribute to their effect on bipolar disorder.

The effect of inositol supplementation on their therapeutic effect in bipolar disease is unknown.

Please review package insert (if available) for further information.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)